Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023.
Antunes L, Mazagatos C, Martínez-Baz I, Gomez V, Borg ML, Petrović G, Duffy R, Dufrasne FE, Dürrwald R, Lazar M, Jancoriene L, Oroszi B, Husa P, Howard J, Melo A, Pozo F, Pérez-Gimeno G, Castilla J, Machado A, Džiugytė A, Karabuva S, Fitzgerald M, Fierens S, Tolksdorf K, Popovici SO, Mickienė A, Túri G, Součková L, Nicolay N, Rose AM; European Hospital Vaccine Effectiveness Group. Antunes L, et al. Among authors: lazar m. Euro Surveill. 2024 Jan;29(3):2300708. doi: 10.2807/1560-7917.ES.2024.29.3.2300708. Euro Surveill. 2024. PMID: 38240061 Free PMC article.
Virological surveillance of influenza viruses in the WHO European Region in 2019/20 - impact of the COVID-19 pandemic.
Melidou A, Pereyaslov D, Hungnes O, Prosenc K, Alm E, Adlhoch C, Fielding J, Sneiderman M, Martinuka O, Celentano LP, Pebody R; WHO European Region influenza surveillance network; WHO European Region Influenza Surveillance Network author list. Melidou A, et al. Euro Surveill. 2020 Nov;25(46):2001822. doi: 10.2807/1560-7917.ES.2020.25.46.2001822. Euro Surveill. 2020. PMID: 33213683 Free PMC article.
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Meslé MMI, Sinnathamby M, Mook P; WHO European Region Respiratory Network Group; Pebody R, Lakhani A, Zambon M, Popovici O, Lazăr M, Ljubović AD, Vukmir NR, Altaş AB, Avci E, Łuniewska K, Szymański K, Gargasiene G, Muralyte S, Dziugyte A, Zahra G, Gonçalves AR, Spedaliero T, Fournier G, Alvarez-Vaca D, Petrović G, Tabain I, Prosenc K, Socan M, Protic J, Dimitrijevic D, Druc A, Apostol M, Kalasnikova KK, Nikisins S, Reiche J, Cai W, Meijer A, Teirlinck A, Larrauri A, Casas I, Enouf V, Vaux S, Lomholt FK, Trebbien R, Jirincova H, Sebestova H, Rózsa M, Molnár Z, Aspelund G, Baldvinsdottir GE, Cottrell S, Moore C, Kossyvakis A, Mellou K, Sadikova O, Tamm JK, Bossuyt N, Thomas I, Staroňová E, Kudasheva L, Pleshkov B, Ikonen N, Helve O, Dickson E, Curran T, Komissarova K, Stolyarov K, Vysotskaya V, Shmialiova N, Rakočević B, Vujošević D, Abovyan R, Sargsyan S, Zakhashvili K, Machablishvili A, Koshalko O, Demchyshyna I, Mandelboim M, Glatman-Freedman A, Gunson R, Karanwal S, Guiomar R, Rodrigues AP, Bennett C, Domegan L, Kalaveshi A, Jakupi X, Ovliyakulova G, Korsun N, Vladimirova N. Meslé MMI, et al. Among authors: lazar m. Influenza Other Respir Viruses. 2023 Nov 20;17(11):e13219. doi: 10.1111/irv.13219. eCollection 2023 Nov. Influenza Other Respir Viruses. 2023. PMID: 38025589 Free PMC article.
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
Maurel M, Pozo F, Pérez-Gimeno G, Buda S, Sève N, Oroszi B, Hooiveld M, Gomez V, Domegan L, Martínez-Baz I, Ilić M, Carnahan AS, Mihai ME, Martínez A, Goerlitz L, Enouf V, Horváth JK, Dijkstra F, Rodrigues AP, Bennett C, Trobajo-Sanmartín C, Mlinarić I, Latorre-Margalef N, Ivanciuc A, Lopez A, Dürrwald R, Falchi A, Túri G, Meijer A, Melo A, O'Donnell J, Castilla J, Vučina VV, Hagey TS, Lazar M, Kaczmarek M, Bacci S, Kissling E; VEBIS study team. Maurel M, et al. Among authors: lazar m. Influenza Other Respir Viruses. 2024 Jan 10;18(1):e13243. doi: 10.1111/irv.13243. eCollection 2024 Jan. Influenza Other Respir Viruses. 2024. PMID: 38204584 Free PMC article.
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.
Maurel M, Howard J, Kissling E, Pozo F, Pérez-Gimeno G, Buda S, Sève N, McKenna A, Meijer A, Rodrigues AP, Martínez-Baz I, Mlinarić I, Latorre-Margalef N, Túri G, Lazăr M, Mazagatos C, Echeverria A, Abela S, Bourgeois M, Machado A, Dürrwald R, Petrović G, Oroszi B, Jancoriene L, Marin A, Husa P, Duffy R, Dijkstra F, Gallardo García V, Goerlitz L, Enouf V, Bennett C, Hooiveld M, Guiomar R, Trobajo-Sanmartín C, Višekruna Vučina V, Samuelsson Hagey T, Lameiras Azevedo AS, Castilla J, Xuereb G, Delaere B, Gómez V, Tolksdorf K, Bacci S, Nicolay N, Kaczmarek M, Rose AM; European IVE group. Maurel M, et al. Among authors: lazar m. Euro Surveill. 2024 Feb;29(8):2400089. doi: 10.2807/1560-7917.ES.2024.29.8.2400089. Euro Surveill. 2024. PMID: 38390651 Free PMC article.
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Lanièce Delaunay C, Martínez-Baz I, Sève N, Domegan L, Mazagatos C, Buda S, Meijer A, Kislaya I, Pascu C, Carnahan A, Oroszi B, Ilić M, Maurel M, Melo A, Sandonis Martín V, Trobajo-Sanmartín C, Enouf V, McKenna A, Pérez-Gimeno G, Goerlitz L, de Lange M, Rodrigues AP, Lazar M, Latorre-Margalef N, Túri G, Castilla J, Falchi A, Bennett C, Gallardo V, Dürrwald R, Eggink D, Guiomar R, Popescu R, Riess M, Horváth JK, Casado I, García MDC, Hooiveld M, Machado A, Bacci S, Kaczmarek M, Kissling E; European Primary Care Vaccine Effectiveness Group. Lanièce Delaunay C, et al. Among authors: lazar m. Euro Surveill. 2024 Mar;29(13):2300403. doi: 10.2807/1560-7917.ES.2024.29.13.2300403. Euro Surveill. 2024. PMID: 38551095 Free PMC article.
Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe.
Maurel M, Mazagatos C, Goerlitz L, Oroszi B, Hooiveld M, Machado A, Domegan L, Ilić M, Popescu R, Sève N, Martínez-Baz I, Larrauri A, Buda S, Túri G, Meijer A, Gomez V, O'Donnell J, Mlinarić I, Timnea O, Diez AO, Dürrwald R, Horváth JK, Dijkstra F, Rodrigues AP, McKenna A, Filipović SK, Lazar M, Kaczmarek M, Bacci S, Kissling E; VEBIS study team. Maurel M, et al. Among authors: lazar m. Vaccine. 2024 Jun 11;42(16):3547-3554. doi: 10.1016/j.vaccine.2024.04.060. Epub 2024 May 3. Vaccine. 2024. PMID: 38704257 Free PMC article.
1,106 results